Latest Breaking News On - Specialty pharma - Page 1 : comparemela.com

Medios : Unternehmenspräsentation - MarketScreener

Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance

EQS-News: Medios AG / Key word: Quarterly / Interim Statement/Quarter Results Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year.

TELES Informationstechnologien : Annual Financial Statements 2023

Translation - the German version is authoritative Annual Report and .

60 Degrees Pharmaceuticals to Sponsor Pilot Study of

60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease..

Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO

～Hidemasa s appointment bolsters Aculys position as a leader in the field of CNS in Japan and Asia～